Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...

As LeBron James fights through injuries, Savannah James opened up about her own health journey with fans.

Morning light resets the rhythm. By evening, levels of a hormone called melatonin begin to surge, triggering drowsiness. Too ...

Former Premier League player Joey Barton has appeared in court, along with another man, charged with assault occasioning grievous bodily harm after an ex-football manager suffered serious injuries ...

Maggie Gyllenhaal’s “The Bride!” is a big, brash swing at a new “The Bride of Frankenstein” that struggles to cohere its many parts. But I’ll say this for it: It’s alive. Just months after Guillermo ...

Maggie Gyllenhaal’s “The Bride!” is a big, brash swing at a new “The Bride of Frankenstein” that struggles to cohere its many ...

Statistically significant improvements in primary endpoint of ammonia control compared with placebo at 36 weeks ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

The members of the homegrown música mexicana band started out playing backyard gigs in San Bernardino. Now, they've built an empire made to last.

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced presentations on SGT-003, its ...

Lundbeck announces last patient randomized ahead-of-schedule in phase 3 MASCOT clinical trial: Valby, Denmark Wednesday, March 11, 2026, 13:00 Hrs [IST] H. Lundbeck A/S (Lundbeck) ...